Skip to main content
. 2009 Sep 14;36(10):4625–4633. doi: 10.1118/1.3218761

Table 1.

Patient’s data.

Patients Gender Tumor location Tumor size (cm3) Comorbid illnessa
P1 F RML 21.51 CHF, MI, colon cancer
P2 F LLL 1.57 COPD, psoriasis
P3 F RLL 4.63 N∕A
P4 M RUL 10.82 COPD, HTN
P5 M LLL 25.24 N∕A
P6 M Mediastinum 78.03 N∕A
P7 M LUL 0.14 COPD, CHF, MI, HTN
P8 F LLL 2.63 AtrialFib, PMR, hyperthyroidism
P9 M RML 4.14 Asthma, tonsillar cancer, H∕N cancer
P10 F RUL 0.67 Breast cancer, colon cancer
P11 M LUL 0.08 CHF, MI, COPD, HTN, PVD
P12 F RUL 2.83 COPD
P13 F RUL 59.33 None
P14 F LUL 2.05 COPD, CHF, MI, PMR
P15 F LLL 5.3 HTN
P16 F LUL 0.76 Rectal∕colon cancer
a

CHF: Congestive heart failure, COPD: Chronic obstructive pulmonary disease, HTN: hypertension, MI: Myocardial infarction (heart attack), PMR: Polymyalgia rheumatica, PVD: Peripheral vascular disease.